Estudio epidemiológico sobre el tratamiento con hemodiálisis en Aragón

• A. Gascón ^[1] ; B. Moragrega ^[1] ; R. Moreno ^[1] ; R. Virto ^[1] ; R. Pernaute ^[1] ; E. Castillón ^[1] ; L.M. Lou ^[1] ; J. Pérez ^[1] ; M.J. Aladrén ^[1] ; F.J. García ^[1] ; R. Gómez ^[1] ; P. Vives ^[1] ; R. Álvarez ^[1] ; J. Castilla ^[1] ; J.A. Gutiérrez ^[1]
  1. [1] Hospital Obispo Polanco

     Hospital Obispo Polanco

     Teruel, España

     
• Localización: Diálisis y trasplante: publicación oficial de la Sociedad Española de Diálisis y Trasplante, ISSN-e 1886-2845, Vol. 25, Nº. 4, 2004, págs. 215-224
• Idioma: español
• Títulos paralelos:
  • Aragon survey on hemodialysis management
• Enlaces
  • Texto completo (pdf)
• Resumen

  • The aim of this study was to know the treatment conditions and medical outcomes between 310 prevalent haemodialysis patients (55% males; mean age 66 ± 13 years) in Aragon. The data shown were collected at 10 haemodialysis units in Aragon. Diabetes mellitus, at 23 percent, was the most common cause of renal insufficiency. The mean (± SD) urea-reduction ratio (URR) was 66.5 ± 8.6%. We observed that 55% of the population reached an URR higher that 65%. The duration of dialysis session was 226 ± 22 minutes, and the rate of blood flow 285 ± 42 mL/min. The percentage of patients with high-flux membranes was 25%. The patterns of vascular access were: 78.2% arteriovenous fistula, 4.2% synthetic graft and 17.6% catheter. Ninety three percent of patients were treated with erythropoietin. The mean dose of erythropoietin was 111 ± 64 UI/kg weight/week. Forty percent of patients had haemoglobin below 11.0 g/dL (mean 11.2 ± 1.7 g/dL). The ferritin levels were below 100 ng/mL in 18% of the patients and 20% showed a transferrin saturation index below 20%. Forty four percent of patients were receiving vitamin D. The mean of main biochemical markers of mineral metabolism were: serum calcium 9.5 ± 1.0 mg/dL; phosphorous 5.6 ± 1.6 mg/dL; calciumphosphorous product 52.8 ± 15.5 mg/dL; PTHi 333 ± 388 pg/mL; and aluminium 27.3 ± 19.9 μg/L. Sixty one percent of patients had phosphorous levels below 6.0 mg/dL. Thirty nine percent of patients had aluminium levels lower than 20 μg/L. The mean serum albumin was 3.6 ± 0.4 g/dL. Thirty one percent of patients had albumin below 3.5 g/dL.